Investors
New England Partner is a Boston based venture capital firm specializing in making equity investments in technology, healthcare, and consumer product companies. NEP collectively has managed over $700 million in sixteen equity funds and have led investments in over 245 portfolio companies, resulting in a successful record of investment realizations through sales, IPO's and mergers. For more information, visit the company's webstie at www.nepartners.com.
Celltrion is one of the largest biopharmaceutical contract manufacturers of therapeutic monoclonal antibodies and recombinant proteins in the world. Celltrion recently completed construction of a 50,000-liter mammalian cell culture facility and initiated an expansion to build an additional 120,000 liters by 2010. Celltrion is headquartered in South Korea in a government-designated Free Economic Zone. This designation has enabled Celltrion to obtain ongoing support from South Korean governmental agencies. The company currently employs 220 people worldwide with a mission to be a leading custom manufacturer of biologics. www.celltrion.com
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. www.olympus.co.jp/en
Maryland Department of Business & Economic Development has an Investment Financing Group that provides emerging high technology businesses access to early-stage capital through their Challenge Investment Program and the Enterprise Investment Fund. For more information, visit the state's website at www.choosemaryland.org.
ASM Resources is the for-profit venture arm of the American Society of Microbiology. Based in Washington DC, ASMR's mission is to provide critical information, advanced training, high-level networking, expert services, and seed capital to bioentrepreneurs and their organizations. For more information, visit the company's webstie at www.asmresources.com.
MedImmune Ventures (NASDAQ:MEDI) is a leading biotechnology company focused on researching, developing and commercializing products to prevent or treat infectious disease, autoimmune disease and cancer. MedImmune actively markets three therapeutic products and has 11 products in clinical testing. MedImmune employs approximately 1,500 people and is headquartered in Maryland. For more information, visit the company’s website at www.medimmune.com .